Broad Reagent Portfolio KPL offers a wide range of over 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays and flow cytometry, presenting multiple cross-sell opportunities across adjacent assays and workflows.

High Sensitivity Focus Emphasize the BacTrace native antigens and polyclonal antibodies designed for optimal signal-to-noise, enabling partners to achieve higher sensitivity and specificity in their diagnostic assays.

Quality and Controls Leverage ACCURUN and AccuPlex quality control products to position SeraCare/KPL as a go-to source for robust positive/negative controls and standardization across assay development and validation workflows.

Clinical Diagnostics Synergy Target collaborations around SARS-CoV-2 related panels and HEV performance materials to support customers developing or validating infectious disease tests, capitalizing on established vaccine/clinical diagnostics momentum.

Global Growth Footprint With a mid-size team and revenue in the mid hundreds of millions, pursue strategic partnerships with mid-market labs and CROs, offering scalable reagent kits and quality solutions to accelerate development timelines.